PERITIA CLINICAL · PHASE 1 → PHASE 3

Protocol depth,
without the hiring cycle.

A pre-vetted network of clinical development, clinical operations, biostatistics, medical writing, and field monitoring specialists — matched to the shape of your program gap in 48 hours or less.

PERITIA CLINICAL · KEY METRICS
4,000+
Vetted monitors
40+
Therapeutic areas
20
Countries
6d
Avg. Phase 3 Ops Lead match
"Peritia had the right expert in place in two weeks. We made the deadline."
— VP Clinical Operations · Series B Biotech
04 CAPABILITY AREAS

Depth, not coverage.

Four capability areas, each with specialist depth by therapeutic area and phase. Every engagement is scoped to the shape of your problem.

01 · CLINICAL DEVELOPMENT & OPERATIONS

Clinical Development

From protocol design through pivotal readout. Study operations, vendor strategy, functional plan orchestration, and program-level leadership for teams moving fast.

  • Protocol design & amendments
  • Study operations & vendor management
  • Functional plan orchestration
  • Program management & delivery
  • IND / FIH planning through Phase 3
02 · BIOSTATISTICS & PROGRAMMING

Biostatistics

Statistical strategy, SAP development, SDTM/ADaM programming, PK/PD modeling, survival analysis — with therapeutic area depth from people who have shipped readouts like yours.

  • Statistical analysis plans
  • SDTM / ADaM / TLF programming
  • PK/PD modeling & population pharmacology
  • Survival & oncology endpoint analysis
  • Interim & futility analyses
03 · MEDICAL WRITING

Medical Writing

Protocols, CSRs, investigator brochures, safety narratives, and regulatory response documents from ex-industry writers with therapeutic area fluency.

  • Protocol & protocol amendments
  • Clinical study reports (CSRs)
  • Investigator brochures
  • Safety narratives & DSURs
  • Regulatory responses & briefing docs
04 · FIELD MONITORING

Field Monitoring

A 4,000+ specialist CRA network across 20 countries. Risk-based monitoring, specialty therapeutic areas, centralized monitoring, and rapid deployment for study rescues.

  • 4,000+ vetted CRAs
  • 20 countries / global deployment
  • Risk-based monitoring (RBM)
  • Centralized monitoring
  • Study rescue & recovery
WHEN CLIENTS CALL US

Three scenarios. One 48-hour promise.

SCENARIO 01

Phase 1 biostat leaves mid-readout.

Your biostats lead takes surprise medical leave three weeks before your Phase 1 readout. You need a replacement who can land inside your EDC and TLF programs — not someone who needs six weeks to onboard.

→ Placed on day 5. Readout on schedule.
SCENARIO 02

Global Phase 3 monitoring gap.

You need to scale monitoring across 14 countries in under a month. Your CRO can't deliver on that timeline. The in-house hiring path is impossible.

→ 22 CRAs deployed across 14 countries in 22 days.
SCENARIO 03

Interim CMO through approval.

Your CMO leaves six months before BLA filing. You cannot hire another full-time CMO in time — but the program cannot move without one.

→ Interim CMO seated in 9 days. 9-month engagement.

Our biostats lead took a surprise medical leave three weeks before our Phase 1 readout. Peritia had a replacement with our therapeutic area experience working inside our EDC by day five.

— HEAD OF CLINICAL DEVELOPMENT · GENE THERAPY · SERIES C

Your clinical gap.
Closed in 48 hours.

Tell us the shape of the problem, not the job description. We return three pre-vetted specialists with therapeutic area fit. First conversation is with a human who has been through this before.